Background/Aims: Although the cure rate of acute promyelocytic leukemia (APL) has exceeded 90%, the relapse/refractory APL that resistant to all-trans retinoic acid (ATRA) or ATO was still serious concern. Matrine (MAT) could improve the differentiation ability of ATRA-resistant APL cells. This study aimed to explore how the APL-specific fusion protein was degraded in ATRA-resistant APL with the application of MAT and ATRA. Methods: ATRA-sensitive (NB4) and ATRA-resistant (NB4-LR1) cell lines were used. Nitroblue tetrazolium reduction assay and flow cytometry were used to detect the differentiation ability. The activity of ubiquitin-proteasome and autophagy-mediated pathways in both cells treated with ATRA with or without MAT were compared ...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological malignancy driven by a chimeric oncoprotein co...
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: In acute promyelocyt...
Acute myeloid leukemia (AML) is characterized by the accumulation of immature blood cell precursors ...
Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form...
Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form...
International audienceAutophagy is one of the main cellular catabolic pathways controlling a variety...
International audienceAutophagy is one of the main cellular catabolic pathways controlling a variety...
Acute myeloid leukemia (AML) is characterized by the accumulation of immature blood cell precursors ...
SummaryRARA becomes an acute promyelocytic leukemia (APL) oncogene by fusion with any of five transl...
In a recent issue of Nature Medicine, Nasr et al. show that the effectiveness of all-trans retinoic ...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological malignancy driven by a chimeric oncoprotein co...
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Objective: In acute promyelocyt...
Acute myeloid leukemia (AML) is characterized by the accumulation of immature blood cell precursors ...
Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form...
Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form...
International audienceAutophagy is one of the main cellular catabolic pathways controlling a variety...
International audienceAutophagy is one of the main cellular catabolic pathways controlling a variety...
Acute myeloid leukemia (AML) is characterized by the accumulation of immature blood cell precursors ...
SummaryRARA becomes an acute promyelocytic leukemia (APL) oncogene by fusion with any of five transl...
In a recent issue of Nature Medicine, Nasr et al. show that the effectiveness of all-trans retinoic ...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological disease characterized by a balanced reciprocal...
Acute promyelocytic leukemia (APL) is a hematological malignancy driven by a chimeric oncoprotein co...